Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
The era of political multipolarity has arrived, and a security framework based on unilateral dependence is only becoming more inadequate against complex threats.
The fierce debate within the party over pro-Israel and anti-Israel positions, sparked by Mamdani, is likely to continue disrupting U.S. politics for the foreseeable future.